Bone Fracture-healing Properties and UPLC-MS Analysis of an Enriched Flavonoid Fraction from Oxystelma esculentum
Planta Medica · 01.02.2024 · 90 (02) · 96-110
DOI: 10.1055/a-2192-2138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.02.2024. Verfasst von Priyanka Rawat und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sophisticated Analytical Instrument Facility & Research, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Fracture Healing, Fractures, Bone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
Oxystelma esculentum has been used as a folk medicine to treat jaundice, throat infections, and skin problems. In the current study, the bone fracture-healing properties of a flavonoid-enriched fraction (Oxy50-60F) of O. esculentum were investigated in Swiss mice using a drill-hole injury model. Oxy50-60F (1 mg/kg/day, 5 mg/kg/day, and 10 mg/kg/day) was administered orally (from the next day) after a 0.6 mm drill-hole injury in mice femur mid-diaphysis for 7 days and 14 days. Parathyroid hormone (40 µg/kg; 5 times/week) was given subcutaneously as the positive control. Confocal imaging for bone regeneration, micro-architecture of femur bones, ex vivo mineralization, hematoxyline and eosin staining, measurement of reactive oxygen species, and gene expression of osteogenic and anti-inflammatory genes were studied. Quercetin, kaempferol, and isorhamnetin glycosides were identified in the active fraction using mass spectrometry techniques. Our results confirm that Oxy50-60F treatment promotes fracture healing and callus formation at drill-hole sites and stimulates osteogenic and anti-inflammatory genes. Oxy50-60F administration to fractured mice exhibited significantly better micro-CT parameters in a dose-dependent manner and promoted nodule mineralization at days 7 and 14 post-injury. Oxy50-60F also prevents ROS generation by increasing expression of the SOD2 enzyme. Overall, this study reveals that Oxy50-60F has bone regeneration potential in a cortical bone defect model, which supports its use in delayed-union and non-union fracture cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sophisticated Analytical Instrument Facility & Research, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India.
- Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India.
ORCID-Profile: Sanjeev Kanojiya
Förderung
- Council of Scientific and Industrial Research, India
Zitieren
APA
Rawat, P., Sharma, K., Khanka, S., Singh, Y., Prakash, R., Rais, N., Maurya, A. K., Gupta, R., Mishra, D. K., Singh, D., & Kanojiya, S. (2024). Bone Fracture-healing Properties and UPLC-MS Analysis of an Enriched Flavonoid Fraction from Oxystelma esculentum. Planta Medica, 90(02), 96-110. https://doi.org/10.1055/a-2192-2138
Vancouver
Rawat P, Sharma K, Khanka S, Singh Y, Prakash R, Rais N, et al. Bone Fracture-healing Properties and UPLC-MS Analysis of an Enriched Flavonoid Fraction from Oxystelma esculentum. Planta Medica. 2024;90(02):96-110. doi:10.1055/a-2192-2138
BibTeX
@article{Rawat2024,
author = {Rawat, Priyanka and Sharma, Kriti and Khanka, Sonu and Singh, Yatendra and Prakash, Ravi and Rais, Nisha and Maurya, Arvind Kumar and Gupta, Ritika and Mishra, Dipak K and Singh, Divya and Kanojiya, Sanjeev},
title = {Bone Fracture-healing Properties and UPLC-MS Analysis of an Enriched Flavonoid Fraction from Oxystelma esculentum},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {02},
pages = {96--110},
doi = {10.1055/a-2192-2138}
}
EUVIMED